Day: May 15, 2024

BranchOut Food Inc. Announces Record First Quarter 2024 Results, Gross Margin Increased to 19%, On Track for ~$8M Run Rate

Written by Customer Service on May 15, 2024. Posted in Earnings Releases And Operating Results.

Achieved a 1,407% revenue increase to $1.47 million in Q1 2024. Increased gross margin to 19% in Q1 2024, up from -3% last year. Secured $8 million in recurring revenue plus $1.1 million in rotational retailer commitments.BEND, Ore., May 15, 2024 (GLOBE NEWSWIRE) — BranchOut Food Inc. (NASDAQ: BOF), a leading food technology company specializing in dehydrated fruit and vegetable-based products, today announced its recent accomplishments and financial results for the first quarter ended March 31, 2024. The Company reported a 1,407% increase in revenue for the first quarter ending March 31, 2024 of $1.47 million compared to $97,000 in the year ago quarter. Additionally, BranchOut Food achieved a gross margin of 19% in Q1 2024, a significant improvement from -3% in Q1 2023. Eric Healy, CEO of BranchOut Food, commented, “This quarter’s...

SPAR Group, Inc. Reports First Quarter 2024 Results

Written by Customer Service on May 15, 2024. Posted in Earnings Releases And Operating Results.

Consolidated Revenues of $68.7 million, up 7% from Last Year U.S. and Canada Revenues up 22% from Last Year Consolidated Operating Income of $9.6 million compared to $3.2 million Last Year Diluted EPS of $0.28 compared to $0.04 Last YearAUBURN HILLS, Mich., May 15, 2024 (GLOBE NEWSWIRE) — SPAR Group, Inc. (NASDAQ: SGRP) (“SPAR,” “SPAR Group” or the “Company”), today announced first-quarter 2024 consolidated revenues of $68.7 million, a 6.7% increase from the first quarter of 2023. Consolidated operating income was $9.6 million, up 204% compared to the first quarter of 2023. Diluted earnings per share were $0.28, including one-time recognition of a $7.2 million pre-tax gain on sale for the quarter, up 600% from the same period in 2023. “I want to thank all of our team for their hard work and efforts,” said Mike Matacunas, SPAR...

Treasure Global Reports Third Quarter Fiscal Year 2024 Results

Written by Customer Service on May 15, 2024. Posted in Earnings Releases And Operating Results.

Reported Gross Profit of Approximately $0.22 Million for Third Quarter Fiscal 2024, up 47% Year-Over-Year Secured a USD$2 million marketing contract aimed to promote prestigious Korean beauty products using its advanced AI Marketing Engine, strategically leveraging the vast revenue potential of the Malaysian and Southeast Asia beauty market Emerged as Exclusive Partner for AI Blockchain Wallet on Telegram, Paving the Way for New Business Opportunities and Spearheading Innovation in the Blockchain Industry Won the silver trophy for Best eCommerce Solution of the MARKETING-INTERACTIVE Asia eCommerce Awards 2023 Successfully Regained Compliance with Nasdaq Minimum Bid Price Requirement. NEW YORK and KUALA LUMPUR, Malaysia, May 15, 2024 (GLOBE NEWSWIRE) — Treasure Global Inc (NASDAQ: TGL) (“TGL,” “Treasure Global” or the “Company”),...

iCAD Reports Financial Results for First Quarter Ended March 31, 2024

Written by Customer Service on May 15, 2024. Posted in Earnings Releases And Operating Results.

NASHUA, N.H., May 15, 2024 (GLOBE NEWSWIRE) — iCAD, Inc. (NASDAQ: ICAD) a global leader on a mission to create a world where cancer can’t hide by providing clinically proven AI-powered breast health solutions, today reported its financial and operating results for the three months ended March 31, 2024. First Quarter 2024 Highlights (Year over Year Performance):Total ARR was $9.0 million, up 10% Total revenues were $5.0 million, up 14% Gross Profit Margin % was 83%, up from 82% GAAP Net Loss from continuing operations ($1.2) million, improvement from ($3.1) million Operating cash flow was ($1.2) million, improvement from ($1.5) million“Over the past year, we have demonstrated strong execution of our three-phased transformation plan that has positioned iCAD for growth and created a platform to drive additional shareholder value,”...

Else Nutrition Reports 2024 First Quarter Financial Results and Provides Business Update

Written by Customer Service on May 15, 2024. Posted in Earnings Releases And Operating Results.

Continuing to add major retail partners; now serving thousands of stores across North America Amazon sales increased approximately 92% and 330% over the same quarter last year in the U.S. and Canada, respectively Conference Call to be Held Today at 10:00 AM Eastern TimeImage: Notable retailers added by Else Nutrition during the first quarter of 2024 VANCOUVER, British Columbia, May 15, 2024 (GLOBE NEWSWIRE) — ELSE NUTRITION HOLDINGS INC. (BABY) (BABYF) (0YL.F) (“Else” or the “Company”), today reported financial results for the first quarter ended March 31, 2024. The financial statements and MD&A are available on SEDAR under the Company’s profile. “We are proud of our strong start to 2024 with multiple, significant retail partners signing on to carry our products,” commented, Hamutal Yitzhak, CEO...

Blüm Holdings Inc. Reports First Quarter 2024 Financial Results

Written by Customer Service on May 15, 2024. Posted in Earnings Releases And Operating Results.

SANTA ANA, Calif., May 15, 2024 (GLOBE NEWSWIRE) — Blum Holdings, Inc. (OTCQB: BLMH) (the “Company,” “Blüm,” “we” or “us”), a cannabis company which through its subsidiaries has operations throughout California, announced its financial results for the first quarter ended March 31, 2024. First Quarter 2024 HighlightsThe Company continued to eliminate non-performing legacy operations during the first quarter of 2024 and transitioned a single retail location to delivery only. As a result, revenue for the first quarter of 2024 was $6.8 million, down from $8.1 million in the previous quarter ended December 31, 2023.For five consecutive quarters in a row, the Company has maintained a gross margin of above 50%, landing at 53% for the first quarter of 2024.Operating expenses for the first quarter of 2024 were $6.1 million, a decrease...

CAPREIT Announces May 2024 Distribution

Written by Customer Service on May 15, 2024. Posted in Dividend Reports And Estimates.

TORONTO, May 15, 2024 (GLOBE NEWSWIRE) — Canadian Apartment Properties Real Estate Investment Trust (“CAPREIT”) (TSX: CAR.UN) announced today its May 2024 monthly distribution in the amount of $0.12083 per Unit (or $1.45 on an annualized basis). The May 2024 distribution will be payable on June 17, 2024 to Unitholders of record at the close of business on May 31, 2024. CAPREIT is Canada’s largest publicly traded provider of quality rental housing. As at March 31, 2024, CAPREIT owns approximately 64,200 residential apartment suites, townhomes and manufactured home community sites well-located across Canada and the Netherlands, with approximately $16.7 billion of investment properties in Canada and Europe. Since its Initial Public Offering in May 1997, CAPREIT has grown monthly cash distributions per Unit by 103%. For more information...

Veru Announces Steven B. Heymsfield M.D. as the Principal Investigator for its Enobosarm Phase 2b Clinical Trial for High Quality Weight Loss

Written by Customer Service on May 15, 2024. Posted in Public Companies.

MIAMI, FL, May 15, 2024 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high quality weight loss, oncology, and viral induced acute respiratory distress syndrome, today announced Steven B. Heymsfield, M.D., a Professor and the Director of the Body Composition-Metabolism Laboratory at the Pennington Biomedical Research Center in Baton Rouge, Louisiana, as the Principal Investigator for the Company’s Phase 2b clinical trial of enobosarm to preserve muscle while augmenting fat loss in patients receiving a GLP-1 RA for weight loss. Dr. Heymsfield is a leading authority on body composition assessment and his research focuses primarily on human obesity, including energy balance regulation, weight loss treatments, co-morbidity...

Atossa Therapeutics Announces Last Patient, Last Dose in its Phase 2 Karisma-Endoxifen Clinical Trial

Written by Customer Service on May 15, 2024. Posted in Public Companies.

SEATTLE, May 15, 2024 (GLOBE NEWSWIRE) — Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”) today announced that the last patient in the Company’s Karisma-Endoxifen clinical trial received their final dose of study medication. Atossa is a clinical stage biopharmaceutical company developing innovative medicines in areas of significant unmet medical need in oncology with a focus on breast cancer. The Karisma-Endoxifen study, which fully enrolled in November 2023, is a 240-person Phase 2 clinical trial investigating (Z)-endoxifen in premenopausal women with measurable mammographic breast density (MBD). Participants were randomized to placebo, 1 mg, and 2 mg daily doses of (Z)-endoxifen and treated for six months, over the course of which mammograms are conducted to measure reduction in MBD. Medication-induced MBD...

Progressive Reports April 2024 Results

Written by Customer Service on May 15, 2024. Posted in Earnings Releases And Operating Results.

MAYFIELD VILLAGE, OHIO, May 15, 2024 (GLOBE NEWSWIRE) — The Progressive Corporation (NYSE:PGR) today reported the following results for the month ended April 30, 2024: April(millions, except per share amounts and ratios; unaudited) 2024Net premiums written $ 6,178.0 Net premiums earned $ 5,575.0 Net income $ 420.3 Per share available to common shareholders $ 0.72 Total pretax net realized gains (losses) on securities $ (266.1 )Combined ratio – current year 89.0 – prior year month 97.9 Average diluted equivalent common shares 587.4 In October 2023, we converted our monthly accounting closing calendar to align with the Gregorian calendar. We do not expect that this change will have a material impact on our reported quarterly and annual underwriting results but it may impact...

Day: May 15, 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals